These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 9606477)
1. A mechanistic approach to antiepileptic drug interactions. Anderson GD Ann Pharmacother; 1998 May; 32(5):554-63. PubMed ID: 9606477 [TBL] [Abstract][Full Text] [Related]
2. Overview of the safety of newer antiepileptic drugs. Shorvon S; Stefan H Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of new antiepileptic drugs. Gram L Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Rekling JC Neurosci Lett; 2003 Jan; 335(3):167-70. PubMed ID: 12531459 [TBL] [Abstract][Full Text] [Related]
5. Update on the mechanism of action of antiepileptic drugs. Meldrum BS Epilepsia; 1996; 37 Suppl 6():S4-11. PubMed ID: 8941036 [TBL] [Abstract][Full Text] [Related]
6. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Hosford DA; Wang Y Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
11. Role of new and established antiepileptic drugs. Leppik IE Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436 [No Abstract] [Full Text] [Related]
12. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs. Perucca E Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245 [TBL] [Abstract][Full Text] [Related]
13. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacokinetics of the new antiepileptic drugs. Perucca E Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Riva R; Albani F; Contin M; Baruzzi A Clin Pharmacokinet; 1996 Dec; 31(6):470-93. PubMed ID: 8968658 [TBL] [Abstract][Full Text] [Related]
16. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Pellock JM; Appleton R Epilepsia; 1999; 40 Suppl 6():S29-38; discussion S73-4. PubMed ID: 10530681 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of the newer antiepileptic drugs. Bialer M Clin Pharmacokinet; 1993 Jun; 24(6):441-52. PubMed ID: 8513648 [TBL] [Abstract][Full Text] [Related]
18. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Johannessen SI Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953 [TBL] [Abstract][Full Text] [Related]